When the brain goes bad, modern medicine is often powerless to help. That's the case for Alzheimer's disease, where drug after drug has failed, and the
Alex LashCatherine Ivy @IvyFoundation wants results in #glioblastoma research. She's getting impatient: “I’ve been doing this for 13 years & invested $90 million. There’s been nothing.” So she's doubling down on a medical team in Phoenix AZ. #GBM, meet Phase Zero.
The earlier cancer is diagnosed, the better the odds of survival, and the race is on to detect the earliest traces of the disease from an otherwise
Alex LashThrive Early Detection (yep that's the full name) is another entrant in the $$ race to screen healthy folks' blood for signs of #Cancer. Late to the game? @ThriveEDTX CEO says no, our test is better b/c it scans for DNA *and* proteins. See what you think
Drugs that rev up a patient's immune system have changed how we treat cancers of the skin, lung, and more, offering people whose tumors have spread a
Alex Lash#immunotherapy checkpoint inhibitors have made big gains in lung, kidney & skin cancer. But not #breastcancer, the deadliest cancer for women. So why won't you see much checkpt data for breast cancer this weekend at #ASCO19? @Benthefidler explains.
Alex Lash#immunotherapy checkpoint inhibitors have made big gains in lung, kidney & skin cancer. But not #breastcancer, the deadliest cancer for women. So why won't you see much checkpt data for breast cancer this wkend at #ASCO2019? @Benthefidler explains. xconomy.com/national/2019/… …
A gene therapy for hemophilia could be on the market by the end of next year, according to its developer BioMarin Pharmaceutical, if regulators agree that
Alex LashTotal number of #HemophiliaA patients in all publicly available #valrox data: 30. About 100 more still to be dosed in Phase 3, but $BMRN says it has enough to ask for approval--and that valrox should work for at least 8 years.